Qkine Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
35
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$3.24M
- Investors
-
16
Qkine General Information
Description
Manufacturer of cytokines and complex proteins intended to advance stem cell, organoid, and regenerative medicines. The company manufactures high-purity, animal-free growth factors, cytokines, and proteins for life science applications, including organoid culture, and combines proprietary production processes with protein engineering technology to tackle fundamental biological and scale-up challenges, enabling clients with the highest purity, bioactive proteins to support its customers best and maximize the impact of their science.
Contact Information
Website
www.qkine.comCorporate Office
- 1 Murdoch House
- Garlic Row
- Cambridge CB5 8HW
- England, United Kingdom
Corporate Office
- 1 Murdoch House
- Garlic Row
- Cambridge CB5 8HW
- England, United Kingdom
Qkine Timeline
Qkine Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Later Stage VC | 02-Sep-2026 | $3.24M | Completed | Generating Revenue | ||
| 10. Secondary Transaction - Private | 01-Jun-2026 | Completed | Generating Revenue | |||
| 9. Later Stage VC | 21-Mar-2025 | Completed | Generating Revenue | |||
| 8. Later Stage VC | 15-Dec-2022 | Completed | Generating Revenue | |||
| 7. Grant | 01-Jan-2021 | Completed | Generating Revenue | |||
| 6. Early Stage VC (Series A) | 08-Jun-2020 | Completed | Generating Revenue | |||
| 5. Seed Round | 01-May-2019 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 10-Jan-2019 | Completed | Generating Revenue | |||
| 3. Seed Round | 23-Apr-2018 | $198K | $198K | Completed | Generating Revenue | |
| 2. Grant | 01-Dec-2017 | $90.6K | Completed | Startup |
Qkine Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 1,051,282 | $0.000135 | $2.64 | $2.64 | 1x | $2.64 | 22.89% | |
| Ordinary | 112,000 | $0.000135 | $1.69 | $1.69 | 1x | $1.69 | 2.44% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Qkine Comparisons
Industry
Financing
Details
Qkine Competitors (9)
One of Qkine’s 9 competitors is R&D Systems, a Corporate Backed or Acquired company based in Minneapolis, MN.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| R&D Systems | Corporate Backed or Acquired | Minneapolis, MN | ||||
| ARVYS Proteins | Corporation | Trumbull, CT | ||||
| ProSpec-Tany TechnoGene | Corporation | East Brunswick, NJ | ||||
| PeproTech | Corporate Backed or Acquired | Cranbury, NJ | ||||
| STEMCELL Technologies | Private Debt Financed | Vancouver, Canada |
Qkine Signals
Qkine Investors (16)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Cambridge Angels | Angel Group | Minority | ||
| Centre for Process Innovation | Corporate Venture Capital | Minority | ||
| EMV Capital | Venture Capital | Minority | ||
| EverQuest Capital Partners | PE/Buyout | Minority | ||
| Meltwind Advisory | Venture Capital | Minority |
Qkine FAQs
-
When was Qkine founded?
Qkine was founded in 2016.
-
Where is Qkine headquartered?
Qkine is headquartered in Cambridge, United Kingdom.
-
What is the size of Qkine?
Qkine has 35 total employees.
-
What industry is Qkine in?
Qkine’s primary industry is Biotechnology.
-
Is Qkine a private or public company?
Qkine is a Private company.
-
What is the current valuation of Qkine?
The current valuation of Qkine is .
-
What is Qkine’s current revenue?
The current revenue for Qkine is .
-
How much funding has Qkine raised over time?
Qkine has raised $12.9M.
-
Who are Qkine’s investors?
Cambridge Angels, Centre for Process Innovation, EMV Capital, EverQuest Capital Partners, and Meltwind Advisory are 5 of 16 investors who have invested in Qkine.
-
Who are Qkine’s competitors?
R&D Systems, ARVYS Proteins, ProSpec-Tany TechnoGene, PeproTech, and STEMCELL Technologies are some of the 9 competitors of Qkine.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process